188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: Preclinical assessment

Mohamed Altai, Helena Wallberg, Hadis Honarvar, Joanna Strand, Anna Orlova, Zohreh Varasteh, Mattias Sandström, John Löfblom, Erik Larsson, Sven Erik Strand, Mark Lubberink, Stefan Stah, Vladimir Tolmachev

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint Dive into the research topics of '188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: Preclinical assessment'. Together they form a unique fingerprint.

Medicine & Life Sciences